paraoxon has been researched along with Aura in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bar-Klein, G; Chai, O; Elkin, M; Friedman, A; Hanael, E; Kaufer, D; Konstantin, L; Peery, D; Senatorov, VV; Shamir, MH; Veksler, R | 1 |
| Bar-Klein, G; Biala, Y; Daninos, M; Friedman, A; Kamintsky, L; Kassirer, M; Krivoy, A; Lavon, O; Makarovsky, I; Ramaty, E; Rosman, Y; Shrot, S; Statlender, L; Yaari, Y | 1 |
1 trial(s) available for paraoxon and Aura
| Article | Year |
|---|---|
Blood-brain barrier dysfunction in canine epileptic seizures detected by dynamic contrast-enhanced magnetic resonance imaging.
Topics: Albumins; Algorithms; Animals; Blood-Brain Barrier; Brain Neoplasms; Contrast Media; Convulsants; Dog Diseases; Dogs; Epilepsy; Gliosis; Magnetic Resonance Imaging; Neuroimaging; Paraoxon; Piriform Cortex; Prospective Studies; Rats; Serum Albumin; Signal Transduction; Status Epilepticus; Transforming Growth Factor beta | 2019 |
1 other study(ies) available for paraoxon and Aura
| Article | Year |
|---|---|
Prevention of organophosphate-induced chronic epilepsy by early benzodiazepine treatment.
Topics: Animals; Antidotes; Atropine; Cholinesterase Inhibitors; Cholinesterase Reactivators; Chronic Disease; Epilepsy; Midazolam; Muscarinic Agonists; Obidoxime Chloride; Paraoxon; Pesticides; Pilocarpine; Rats; Rats, Sprague-Dawley; Status Epilepticus | 2014 |